Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice.

MLA

Chen, Sing-Young, et al. “Head-to-Head Comparison of BAM15, Semaglutide, Rosiglitazone, NEN, and Calorie Restriction on Metabolic Physiology in Female Db/Db Mice.” BBA: Molecular Basis of Disease, vol. 1870, no. 1, Jan. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bbadis.2023.166908.

APA

Chen, S.-Y., Beretta, M., Olzomer, E. M., Alexopoulos, S. J., Shah, D. P., Byrne, F. L., Salamoun, J. M., Garcia, C. J., Smith, G. C., Larance, M., Philp, A., Turner, N., Santos, W. L., Cantley, J., & Hoehn, K. L. (2024). Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice. BBA: Molecular Basis of Disease, 1870(1), N.PAG. https://doi.org/10.1016/j.bbadis.2023.166908

Chicago

Chen, Sing-Young, Martina Beretta, Ellen M. Olzomer, Stephanie J. Alexopoulos, Divya P. Shah, Frances L. Byrne, Joseph M. Salamoun, et al. 2024. “Head-to-Head Comparison of BAM15, Semaglutide, Rosiglitazone, NEN, and Calorie Restriction on Metabolic Physiology in Female Db/Db Mice.” BBA: Molecular Basis of Disease 1870 (1): N.PAG. doi:10.1016/j.bbadis.2023.166908.